Postoperative serum and whole blood selenium levels in patients with squamous cell and adenocarcinomas of the uterus after curative surgical treatment

Trace Elements and Electrolytes

Volumn 26, Issue 2, 2009, Pages 78-82

  Muecke, R ^a,h   Buentzel, J ^b,h   Glatze, M ^c,h   Bruns, F ^d,h   Kisters, K ^e,h   Prott, F J ^a   Schmidberger, H ^f   Micke, O ^g,h  

^a ST JOSEFS HOSPITAL   (Germany)

^b Department of Otolaryngology   (Germany)

^c Suhl Central Hospital   (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e ST ANNA HOSPITAL   (Germany)

^f JOHANNES GUTENBERG UNIVERSITY   (Germany)

^g FRANZISKUS HOSPITAL   (Germany)

^h German Working Group Trace Elements and Electrolytes in Oncology   (Germany)

Author keywords

Radiotherapy; Serum and whole blood selenium levels; Squamous cell and adenocarcinomas of the uterus after curative surgical treatment

Indexed keywords

SELENIUM;

AGED; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SELENIUM BLOOD LEVEL; SQUAMOUS CELL CARCINOMA; TRACE METAL BLOOD LEVEL; UTERUS CARCINOMA; UTERUS SURGERY;

EID: 70350428226     PISSN: 09462104     EISSN: None     Source Type: Journal    
DOI: 10.5414/tep26078     Document Type: Article

References (34)

1. Brooks JD, Metter EJ, Chan DW. Plasma selenium level before diagnosis and the risk of prostate cancer development. J Urolog. 2001; 166: 2034-2038.
2. Buentzel J, Muecke R, Micke O. Mineral status and enzymatic antioxidative capacities during radiochemotherapy in patients with advanced head and neck cancer. Trace Elem Electrolytes. 2000; 18: 98.
3. Clark LC. The epidemiology of selenium and cancer. Fed Proc. 1985; 44: 2584.
4. Clark LC, Combs GF, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, Krongrad A, Lesher JL, Park HK, Sanders BB, Smith CI, Taylor JR. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. JAMA 1996; 276: 1957-1963.
5. Coates RJ, Weiss NS, Dailing JR, Morris JS, Labbe RF. Serum levels of selenium and retinal and subsequent risk of cancer. Am J Epidem. 1988; 135: 115-121.
6. Diamond AM, Dale P, Murray JL, Grdina DJ. The inhibition of radiation-induced mutagenesis by the combined effects of selenium and the aminothiol WR-1065. Mutation Research. 1996; 356: 147-154.
7. Iyengar V, Woittiez J. Trace elements in human clinical specimens: evaluation of literature data to identify reference values. Clin Chem. 1988; 34: 474-480.
8. Knekt P, Aromaa A, Mantela J. Serum vitamin E, serum selenium and the risk of gastrointestinal cancer. Int J Cancer. 1988; 42: 846-850.
9. Knekt P, Aromaa A, Mantela J. Serum selenium and subsequent risk of cancer among Finnish men and woman. J Natl Cancer Inst. 1990; 82: 864-868.
10. Lalonde L, Jean Y, Roberts KD, Chapdelaine A, Bleau G. Fluorometry of selenium in serum or urine. Clin Chem. 1982; 28: 172-174.
11. Last KW, Cornelius V, Delves T, Sieniawska Ch, Fitzgibbon J, Norton A, Amess J, Wilson A, Rohatiner A, Lister AT. Presentation serum selenium predicts for overall survival, dose delivery, and first treatment response in aggressive non-Hodgkin's lymphoma. J Clin Oncol.2003; 21: 2335-2341.
12. Menkes MS. Serum β-carotene, vitamin A and E, Se and the risk of lung cancer. N Engl J Med. 1986; 315: 1250-1254.
13. Muecke R, Jaekel R, Steiner M, Anders O, Ernst B. Erythrocyte and whole blood superoxide dismutase activity in chronic myeloproliferative disorders. Klin Lab. 1994; 40: 323-326.
14. Muecke R, Micke O, Schoenekaes KG. Serum selenium levels, glutathione peroxidase and serum redox potential in patients with untreated non-small cell lung cancer and adenocarcinoma of the rectum. Trace Elem Electrolytes. 2000; 17: 119-123.
15. Muecke R, Micke O, Schoenekaes KG, Buentzel J. Is a supplementation of selenium advisable during radiotherapy and radiochemotherapy of patients with malignant diseases. Trace Elem Electrolytes. 2000; 17: 194-195.
16. Muecke R, Glatzel M, Reichl B, Bernd-Skorka R, Buentzel J, Bruns F, Kisters K, Prott FJ, Micke O. Sodium selenite in gynecologic radiation oncology - results of a prospective randomized observation study. Trace Elem Electrolytes. 2006; 23: 173-177.
17. Newberne PM, Charley G, Adams K, Cantor M, Roth D, Supharkan V. Gastric and oesophageal carcinogenesis. Fd Chem Toxic. 1986; 24: 1111-1119.
18. Oberley LW, Oberley TD. The role of antioxidant enzymes in cell immortalization and transformation. Mol Cell Biochem. 1988; 84: 147-153.
19. Patchen ML, MacVittie TJ, Weiss JF. Combined modality radioprotection: the use of glucan and selenium with WR-2721. Int J Radiat Oncol Biol Phys.1990; 18: 1069-1075.
20. Pawlowicz Z, Zachara BA, Trafikowska U, Maciag A, Marchaluk E, Nowicki A. Blood selenium concentrations and glutathione peroxidase activities in patients with breast cancer and with advanced gastrointestinal cancer. J. Trace Elem Electrolytes Health Dis. 1991; 5: 272-277.
21. Pawlowicz Z, Zachara BA, Trafikowska U, Nowicki A. Low levels of selenium and activity of glutathione peroxidase in blood of patients with gastrointestinal neoplasma. Pol Tyg Lek.1993; 48: 554-556.
22. Punnonen R, Kudo R, Punnonen K, Hietanen E, Kuoppala T, Kainulainen H, Sato K, Ahotupa M. Activities of antioxidant enzymes ans lipid peroxidation in endometrial cancer. Eur J Cancer. 1993; 65: 266-269.
23. Rayman MP. The importance of selenium to human health. Lancet 2000; 356: 233-241.
24. Ringstad J, Jacobsen BK, Tretli S, Thomassen Y. Serum selenium concentration associated with risk of cancer. J Clin Pathol 1988; 41: 454-457.
25. Salonen JT, Alfthan G, Huttunen JK, Puska P. Association between serum selenium and the risk of cancer. Am J Epidemiol. 1984; 120: 342-349.
26. Salonen JT, Salonen R, Lappeteläinen R, Mäenpää PH, Alfthan G, Puska P. Risk of cancer in relation to serum concentrations of selenium and vitamins A and E. BMJ 1985; 290: 417-420.
27. Schueller P, Puettmann S, Muecke R, Senner V, Schaefer U, Kisters K, Micke O. From the radiolysis of water to the role of trace elements in radiobiology and clinical radiation therapy: following a logical chain. Trace Elem Electrolytes 2001; 18: 186-192.
28. Shu-You Y, Ya-Jun Z, Wen-Guang Li, Qui-Sheng H, Zhi-Huang Ch, Qi-Nan Zh, Chong H. A preliminary report on the intervention trials of primary liver cancer in high-risk populations with nutritional supplementation of selenium in china. Biol Trace Elem Res. 1991; 29: 289-294.
29. Torun M, Aldemir H, Yardim S. Serum selenium levels in various cancer types. Trace Elem Electrolytes. 1995; 12: 186-190.
30. Turan B, Delilbasi E. The serum selenium and immunoglobulin levels in healthy and cancer cases. J Biochem. 1992; 17: 29-36.
31. Vermeulen N, Baldew GS, Los G, McVie JG, De Goeij JM. Reduction of cisplatinum nephrotoxicity by sodium selenite. Drug Metabol Dispos.1993; 21: 30-36.
32. Willet W, Polk P, Morris S. Prediagnostic serum selenium and risk of cancer. Lancet 1983; 2: 130-134.
33. Winnefeld K, Dawczynski H, Schirrmeister W, Adam G, Friedrich U, Hein S. Selenium in serum and whole blood in patients with surgical interventions. Biol Trace Elem Res. 1995; 50: 149-155.
34. Zachara BA, Szewczyk-Golec K, Wolski Z, Tyloch J, Skok Z, Bloch-Boguslawska E, Wasowicz W. Selenium level in benign and cancerous prostate. Biol Trace Elem Res. 2005; 103: 199-206.